chr7-107702019-T-A
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP2
The NM_000441.2(SLC26A4):c.1996T>A(p.Ser666Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S666F) has been classified as Uncertain significance.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- Pendred syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- athyreosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hypoplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC26A4 | NM_000441.2 | c.1996T>A | p.Ser666Thr | missense_variant | Exon 17 of 21 | ENST00000644269.2 | NP_000432.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC26A4 | ENST00000644269.2 | c.1996T>A | p.Ser666Thr | missense_variant | Exon 17 of 21 | NM_000441.2 | ENSP00000494017.1 | |||
| SLC26A4 | ENST00000492030.2 | n.283T>A | non_coding_transcript_exon_variant | Exon 2 of 6 | 5 | |||||
| SLC26A4 | ENST00000644846.1 | n.706T>A | non_coding_transcript_exon_variant | Exon 7 of 10 | ENSP00000494344.1 | |||||
| SLC26A4 | ENST00000480841.5 | n.*135T>A | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251212 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461652Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727152 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Ser666Thr variant in SLC26A4 has not been reported in the literature nor pre viously identified by our laboratory. However, a different amino acid change at this location (Ser666Phe) has previously been reported to be pathogenic (Ishihar a 2010, Tsukamoto 2003), which increases the likelihood that this variant is als o pathogenic. However, computational analyses (PolyPhen, SIFT, AlignGVGD) sugges t this variant is less likely to impact to the protein though this information i s not very predictive of pathogenicity. This residue is conserved in mammals tho ugh not in lower species. In summary, the clinical significance of this variant cannot be determined with certainty at this time.
Pendred syndrome Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at